Off-Label Crisis Workshop Offers Real-World Solutions to Identify, Minimize Risky Practices

    FALLS CHURCH, Va., Aug. 24 /PRNewswire/ -- FDAnews announced today a
 special two-day, hands-on workshop: THE OFF-LABEL CRISIS WORKSHOP: IDENTIFY
 AND ELIMINATE RISKY PRACTICES BEFORE IT'S TOO LATE
     This workshop is scheduled Sept. 20-21, 2005 at the Loews Philadelphia
 Hotel in Philadelphia, PA.
     It's a proactive way to secure your company before bad practices lead to
 investigations, prosecutions and lost profit. Learn from the only interactive
 two-day workshop exclusively designed to help you tackle this costly and
 growing problem.
     Even drug and device companies that haven't intentionally violated the law
 are being singled out for prosecution! This is NOT the time to be complacent!
     Register today for THE OFF-LABEL CRISIS WORKSHOP. Let expert litigators
 and compliance officers from McGuireWoods, Purdue Pharma and Deloitte help you
 identify and minimize your exposure.
     The workshop will focus on the emerging crisis drug and device firms face
 as federal and state prosecutors crack down on off-label promotion practices.
 
     WORKSHOP ATTENDEES WILL LEARN
 
      -- Key factors that trigger off-label promotion risks
 
      -- What you must know about federal and state initiatives in off-label
         crackdowns
 
      -- What the Federal False Claims Act really means to your operations
 
      -- How to structure effective internal reviews
 
      -- How to respond to government inquiries and investigations
 
      -- How to minimize penalties for violations -- both civil and criminal
 
      -- Best methods for dealing with whistle-blowers and wrongful discharge
         claims
 
      -- Proven strategies for continuous monitoring and improvement
 
     WORKSHOP TUITION
     Registration: $1,795. Tuition includes two days of training and
 interactive sessions, training materials (presentation slides and reference
 material), continental breakfast and lunch each day, and first evening
 reception.
       Online enrollment:
       http://www.fdanews.com/wbi/conferences/offlabelcrisis.html
       Phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
       Fax: +1 (703) 538-7676
 
     PRESENTED BY FDANEWS
     FDAnews is the premier provider of global regulatory, legislative and
 business news and information for professionals in industries regulated by the
 FDA and the European Medicines Agency. Pharmaceutical and medical device
 professionals rely on FDAnews' conferences, print and electronic newsletters,
 and books to stay in compliance with international standards and FDA's complex
 and ever-changing regulations.
 
     CONTACT: Jeff Grizzel
              Conference Director
              FDAnews
              300 N Washington St Ste 200
              Falls Church VA USA 22046
              703-538-7600 phone
              http://www.fdanews.com
 
 

SOURCE  FDAnews